A test based on a panel of microRNAs under development in Israel may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.
A test based on a panel of microRNAs under development in Israel may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.